Search by Drug Name or NDC
NDC 00527-4125-35 DRONABINOL 2.5 mg/1 Details
DRONABINOL 2.5 mg/1
DRONABINOL is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is DRONABINOL.
MedlinePlus Drug Summary
Dronabinol is used to treat nausea and vomiting caused by chemotherapy in people who have already taken other medications to treat this type of nausea and vomiting without good results. Dronabinol is also used to treat loss of appetite and weight loss in people who have acquired immunodeficiency syndrome (AIDS). Dronabinol is in a class of medications called cannabinoids. It works by affecting the area of the brain that controls nausea, vomiting, and appetite.
Related Packages: 00527-4125-35Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dronabinol
Product Information
| NDC | 00527-4125 |
|---|---|
| Product ID | 0527-4125_aac4561c-b9ba-4d3a-b86c-be120e4593dc |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | DRONABINOL |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dronabinol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | DRONABINOL |
| Labeler Name | Lannett Company, Inc. |
| Pharmaceutical Class | Cannabinoid [EPC], Cannabinoids [CS] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA207421 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00527-4125-35 (00527412535)
| NDC Package Code | 0527-4125-35 |
|---|---|
| Billing NDC | 00527412535 |
| Package | 60 CAPSULE in 1 BOTTLE (0527-4125-35) |
| Marketing Start Date | 2020-02-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |